Potential for regenerative medicine and cancer research earns doctoral student Ido Sagi a Kaye Innovation Award
Stem cell research holds huge potential for medicine and human health. In particular, human embryonic stem cells (ESCs), with their ability to turn into any cell in the human body, are essential to the future prevention and treatment of disease.
One set or two? Diploid versus haploid cells
Most of the cells in our body are diploid, which means they carry two sets of chromosomes — one from each parent. Until now, scientists have only succeeded in creating haploid embryonic stem cells — which contain a single set of chromosomes — in non-human mammals such as mice, rats and monkeys. However, scientists have long sought to isolate and replicate these haploid ESCs in humans, which would allow them to work with one set of human chromosomes as opposed to a mixture from both parents.
This milestone was finally reached when Ido Sagi, working as a PhD student at the Hebrew University of Jerusalem’s Azrieli Center for Stem Cells and Genetic Research, led research that yielded the first successful isolation and maintenance of haploid embryonic stem cells in humans. Unlike in mice, these haploid stem cells were able to differentiate into many other cell types, such as brain, heart and pancreas, while retaining a single set of chromosomes.
With Prof. Nissim Benvenisty, Director of the Azrieli Center, Sagi showed that this new human stem cell type will play an important role in human genetic and medical research. It will aid our understanding of human development – for example, why we reproduce sexually instead of from a single parent. It will make genetic screening easier and more precise, by allowing the examination of single sets of chromosomes. And it is already enabling the study of resistance to chemotherapy drugs, with implications for cancer therapy.
Diagnostic kits for personalized medicine
Based on this research, Yissum, the Technology Transfer arm of the Hebrew University, launched the company New Stem, which is developing a diagnostic kit for predicting resistance to chemotherapy treatments. By amassing a broad library of human pluripotent stem cells with different mutations and genetic makeups, NewStem plans to develop diagnostic kits for personalized medication and future therapeutic and reproductive products.
The Latest on: Haploid embryonic stem cells
- Genetically Modified Food - Latest News and Research Updateson June 23, 2020 at 5:00 pm
Medindia provides you with the latest news and research breakthroughs on Genetically Modified Food. Please find ... senior author Carl Jun Haploid Embryonic Stem Cells can be Used to Produce ...
- Overcoming genomic imprinting barrier improves mammal cloningon June 19, 2020 at 5:43 am
Somatic cell nuclear transfer (SCNT, also known as cloning) technology holds great potential in animal production and regenerative medicine. However, the extremely low efficiency and frequently ...
- The Stages of Early Embryonic Developmenton June 17, 2020 at 8:18 am
The initial growth stages of multi-cellular organisms start with a zygote cell, which then undergoes fast cell division to form the initial cell cluster, or ‘blastula’. This rapid division of cells is ...
- Knock Out, Knock In, Knock Down — Genetically Manipulated Mice and the Nobel Prizeon June 10, 2020 at 5:00 pm
The concept of genetically engineering a mouse is straightforward: devise a specific genetic modification in a chromosome of embryonic stem cells ... germ cell, yielding a haploid gamete.
- Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleleson June 8, 2020 at 8:08 am
Using optimized screening workflows, we performed essentialome screens in cancer cell lines and embryonic stem cells and achieved dropout efficiencies that could not be explained by common ...
- p53’s Multiple Roles Are Acquired during Pluripotent Stem Cell Differentiationon June 1, 2020 at 1:17 pm
However, previous efforts to determine whether p53 is behind apoptosis induced by DNA damage in pluripotent embryonic stem cells (ESCs ... formation of haploid cells, increased genomic stability ...
- Rejuvenated fibroblasts can recover the ability to contracton May 26, 2020 at 10:25 am
This encouraging discovery holds great potential for applications in regenerative medicine and stem cell engineering. Fibroblasts are the most common connective tissue cells. They produce the ...
- Tracking intracellular forces and mechanical property changes in mouse one-cell embryo developmenton May 24, 2020 at 5:00 pm
Cells comprise mechanically active matter that ... programme that is necessary for development at the origin of a new embryonic life.
- Meiosis occurs normally in the fetal ovary of miceon May 22, 2020 at 10:56 am
Fig. 1. Expression of RARs in the female gonad and in germ cells during embryonic development. (A and B) Detection of RARA and RARG (red signals) on frontal histological sections of an E11.5 wild-type ...
- Types of Publicationson November 7, 2017 at 12:51 am
Pettitt, S.J. Tan, E.-. Yusa, K. (2015). piggyBac Transposon-Based Insertional Mutagenesis in Mouse Haploid Embryonic Stem Cells. , , pp. 15-28. Pettitt, S.J. Rehman ...
via Google News and Bing News